Thiogenesis Therapeutics, Corp.
TTIPF
$0.42
-$0.03-6.67%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -69.06% | -55.93% | -18.09% | -62.78% | -48.59% |
| Total Receivables | -52.51% | -8.35% | -10.11% | 2.30% | -43.63% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 67.92% | 169.18% | 61.48% | 4.41% | -15.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -66.07% | -52.19% | -17.34% | -61.55% | -48.11% |
|
|
|||||
| Total Current Assets | -66.07% | -52.19% | -17.34% | -61.55% | -48.11% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -66.07% | -52.19% | -17.34% | -61.55% | -48.11% |
|
|
|||||
| Total Accounts Payable | 31.89% | 133.38% | 1,240.05% | 382.61% | 166.92% |
| Total Accrued Expenses | -47.50% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 30.51% | 133.38% | 1,247.96% | 382.61% | 171.63% |
|
|
|||||
| Total Current Liabilities | 30.51% | 133.38% | 1,247.96% | 382.61% | 171.63% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 30.51% | 133.38% | 1,247.96% | 382.61% | 171.63% |
|
|
|||||
| Common Stock & APIC | 26.83% | 29.55% | 23.25% | 3.92% | -2.44% |
| Retained Earnings | -48.79% | -59.50% | -47.27% | -41.25% | -24.79% |
| Treasury Stock & Other | 57.63% | 57.73% | 31.66% | 15.29% | -0.56% |
| Total Common Equity | -110.93% | -82.40% | -49.65% | -90.36% | -62.28% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -110.93% | -82.40% | -49.65% | -90.36% | -62.28% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -110.93% | -82.40% | -49.65% | -90.36% | -62.28% |
|
|
|||||